Capital International Inc. CA Has $64.28 Million Position in CVS Health Corporation $CVS

Key Points

• Capital International Inc. CA increased its stake in CVS by 27.9% in Q3, adding 185,811 shares to hold 852,690 shares worth $64.28 million (about 0.07% of the company).
• CVS beat quarterly estimates, reporting $1.09 EPS versus $1.00 expected and $105.69 billion in revenue versus $103.67 billion, and set FY2026 guidance of $5.940–$6.140 EPS (sell‑side forecast ~5.89).
• CVS pays a $0.665 quarterly dividend (annualized $2.66, yield 3.4%), but its payout ratio is high at 192.75%.

Capital International Inc. CA lifted its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 27.9% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 852,690 shares of the pharmacy operator's stock after buying an additional 185,811 shares during the quarter. Capital International Inc. CA owned about 0.07% of CVS Health worth $64,284,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Harbor Capital Advisors Inc. lifted its holdings in CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator's stock worth $26,000 after purchasing an additional 142 shares during the last quarter. Corundum Trust Company INC acquired a new stake in shares of CVS Health during the third quarter worth $29,000. Front Row Advisors LLC boosted its position in shares of CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator's stock valued at $31,000 after acquiring an additional 371 shares during the period. Twin Peaks Wealth Advisors LLC bought a new position in CVS Health during the second quarter worth about $36,000. Finally, SOA Wealth Advisors LLC. increased its position in CVS Health by 36.9% during the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator's stock worth $37,000 after acquiring an additional 131 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

CVS Health Stock Performance

Shares of CVS opened at $78.25 on Tuesday. The stock has a 50 day moving average of $78.46 and a 200 day moving average of $77.70. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. CVS Health Corporation has a 12 month low of $58.35 and a 12 month high of $85.15. The company has a market capitalization of $99.55 billion, a price-to-earnings ratio of 56.70, a PEG ratio of 0.81 and a beta of 0.49.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts' consensus estimates of $1.00 by $0.09. The firm had revenue of $105.69 billion for the quarter, compared to analysts' expectations of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The company's quarterly revenue was up 8.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, sell-side analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were paid a $0.665 dividend. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. CVS Health's payout ratio is presently 192.75%.

Analysts Set New Price Targets

A number of brokerages have issued reports on CVS. Weiss Ratings restated a "hold (c-)" rating on shares of CVS Health in a research report on Monday, December 29th. Royal Bank Of Canada reiterated an "outperform" rating on shares of CVS Health in a research report on Thursday, December 4th. Piper Sandler restated an "overweight" rating and issued a $101.00 price target (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Wolfe Research reduced their price objective on shares of CVS Health from $100.00 to $97.00 and set an "outperform" rating on the stock in a research note on Monday, March 2nd. Finally, TD Cowen upped their price target on shares of CVS Health from $100.00 to $105.00 and gave the stock a "buy" rating in a report on Wednesday, December 10th. Nineteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $94.91.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.